GOLDENTREE ASSET MANAGEMENT LP 4
4 · Keenova Therapeutics plc · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Keenova Therapeutics — GoldenTree (10% Owner) Acquires 33,651 Shares
What Happened GoldenTree Asset Management (reporting via GoldenTree Asset Management LP/LLC and Steven A. Tananbaum) recorded an acquisition of 33,651 Keenova Therapeutics ordinary shares on July 31, 2025. The shares were received as part of a merger transaction (Endo, Inc. merged into a Keenova subsidiary) where Endo shares were cancelled and converted into Keenova ordinary shares and cash under the transaction agreement. No per‑share price or dollar value was disclosed in the Form 4.
Key Details
- Transaction date: July 31, 2025 (reported on Form 4 filed Feb 12, 2026 — filing was delayed by ~6.5 months).
- Transaction type/code: Other acquisition/disposition (J) — conversion via corporate action/merger.
- Shares acquired: 33,651 ordinary shares (price = N/A; consideration included both shares and cash per the transaction agreement).
- Shares reported owned as of filing: 7,979,827 total ordinary shares (7,926,212 held by funds/accounts managed by the Advisor; 53,615 held directly by Steven A. Tananbaum).
- Reporting persons: GoldenTree Asset Management LP (Advisor), GoldenTree Asset Management LLC (General Partner), and Steven A. Tananbaum — the Advisor may be deemed to have a pecuniary interest in fund holdings; the Advisor/GP and Mr. Tananbaum disclaim beneficial ownership of the shares held by the funds.
- Footnote context: F1 explains the merger conversion; F2 notes reported ownership includes securities from other previously reported purchases.
Context This was an institutional conversion tied to a corporate merger, not an open‑market purchase or executive sale. As a reported 10% owner and investment adviser, GoldenTree’s activity reflects fund holdings and structural ownership changes from the merger rather than a manager’s personal trading decision. The delayed filing should be noted by investors, as on‑time reporting is important for transparency.
Insider Transaction Report
- Other
Ordinary Shares
[F1][F2][F3][F4][F5]2025-07-31+33,651→ 7,979,827 total(indirect: See footnotes)
Footnotes (5)
- [F1]Pursuant to the transaction agreement (the "Transaction Agreement") between Endo, Inc. ("Endo") and Salvare Merger Sub LLC, a wholly owned subsidiary of the Issuer ("Merger Sub"), on July 31, 2025, Merger Sub merged with and into Endo (the "Merger"), with Endo surviving the Merger as a wholly owned subsidiary of the Issuer. As a result of the Merger, certain shares of common stock of Endo were cancelled and converted into the right to receive a number of Ordinary Shares of the Issuer and cash consideration as set forth in the Transaction Agreement.
- [F2]The amount reported herein reflects ownership as of the date of this filing and includes securities acquired in purchases previously reported on Forms 4 following the date of the reported transaction.
- [F3]This Form 4 is filed on behalf of GoldenTree Asset Management LP (the "Advisor"), GoldenTree Asset Management LLC (the "General Partner") and Steven A. Tananbaum (collectively, the "Reporting Persons"). The Advisor is the investment manager or advisor to certain funds and separate accounts managed by the Advisor (the "Funds") and may be deemed to have a pecuniary interest in the securities directly held by the Funds. The General Partner is the general partner of the Advisor and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor has a pecuniary interest. Steven A. Tananbaum is the managing member of the General Partner and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor and the General Partner have a pecuniary interest.
- [F4]The Advisor, the General Partner, and Mr. Tananbaum disclaim beneficial ownership of the Ordinary Shares held by the Funds.
- [F5]The securities reported herein include 7,926,212 Ordinary Shares held directly by certain funds and separate accounts managed by the Advisor and 53,615 Ordinary Shares held directly by Mr. Tananbaum.